IL17RA and ulcerative colitis: A recent study has demonstrated that Gingerenone A, a phenolic compound isolated from Zingiber officinale, is able to improve intestinal mucosal inflammation and restore intestinal barrier homeostasis by inhibiting IL-17RA signaling to ameliorate ulcerative colitis (UC) [39].